BOAZ CHEUNG

PARTNER

OVERVIEW

Boaz is a solicitor qualified in Hong Kong. He graduated from the University of Hong Kong and obtained his Bachelor of Social Sciences (Government and Laws) degree, Bachelor of Laws degree and Postgraduate Certificate in Laws (PCLL).

Boaz's areas of practice cover corporate finance, merger and acquisition and general corporate and commercial matters. His capital market experience covers both primary and secondary issues. In primary issues, he represents issuers and sponsors in initial public offerings on the Main Board and GEM of the Stock Exchange of Hong Kong Limited. He also represents issuers in secondary issues by way of placing of share, rights issue and subscription of shares and/or convertible securities. Boaz also advises on mergers acquisitions, corporate restructuring, and main board and GEM listed issuers in respect of the compliance with Listing Rules and Takeovers Code.

WORK HIGHLIGHTS
  • Advising Oceanwide Holdings Co., Ltd. (a company listed on the Shenzhen Stock Exchange, stock Code: 000046) on its acquisition of 71.36% of equity interest in Hutchison Harbour Ring Limited (stock code: 715, “Hutchison Harbour Ring”) through its wholly-owned subsidiary, Oceanwide Holdings International Co., Ltd, for a total consideration of HK$38.2 billion, and the subsequent unconditional mandatory cash offers for all the remaining shares of Hutchison Harbour Ring at a maximum value of approximately HK$15.3 billion.

  • Advising Global Link Communications Holdings Limited (Stock Code: 8060) in responding the unconditional mandatory cash offers made by China Galaxy International Securities (Hong Kong) Co., Limited for and on behalf of Honor Crest Holdings Limited, a wholly-owned subsidiary of International Elite Ltd. (Stock Code: 1328).

  • Advising Consun Pharmaceutical Group Limited (Stock code: 1681) on its share repurchase from First Kind Limited, wholly owned subsidiary of Hony Capital Fund III, L.P for a total consideration of HK$561 million. This transaction constitutes an off-market share buy back under the Takeovers Code.

  • Advising NT China NT Pharma Group Company Limited on its issuance of convertible preference shares in the amount of HK$ 590 million.

  • Advising Consun Pharmaceutical Co., Ltd. (Stock Code: 1681) on   its initial public offering on the Main Board of the Hong Kong Stock Exchange raising approximately HK$1 billion (including over-size allotment options).

  • Advising Guotai Junan Capital Limited as sole sponsor, in connection with the listing of H-shares of Chanjet Information Technology Company Limited on the Main Board of the Hong Kong Stock Exchange. The issuer being a subsidiary of Yonyou Software Co., Ltd. (a company currently listed on the Shanghai Stock Exchange (stock code: 600588)), this project was the first spin off listings of A-share listed companies on the Hong Kong Stock Exchange.

  • Advising Guotai Junan Capital Limited as sole sponsor, in connection with the global offering and IPO of H-shares of Chamracy  Pharmaceutical Co., Ltd. (Stock Code: 2289) on the Main Board of the Hong Kong Stock Exchange.

  • Advising Guotai Junan Capital Limited as sole sponsor, in connection with the global offering and IPO of H-shares of Holly Futures Co., Ltd (Stock Code: 3678) on the Main Board of the Hong Kong Stock Exchange.

  • Advising Ever Harvest Group Holdings Limited (Stock Code: 1549) on its listing on the Main Board of the Stock Exchange.

  • Advising WAC Holdings Limited (Stock Code: 8619) on its listing on GEM of the Stock Exchange.

Home | About Us | DeHeng Law Offices Our Expertise | Our People | Careers | Contact | Privacy Policy | Disclaimers

© 2020 Chungs Lawyers in association with DeHeng Law Offices. All rights reserved.